Related Experiment Video
Updated: May 9, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy
Kalkidan Bishu1, Margaret M Redfield
1Mayo Clinic Cardiovascular Research, Guggenheim 9, 200 First Street Southwest, Rochester, MN 55905, USA.
Insights
Acute heart failure in patients with preserved ejection fraction (HFpEF) accounts for half of all cases. Current guidelines lack evidence-based strategies for managing AHF in HFpEF, highlighting a critical unmet need.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Acute heart failure (AHF) leads to 1 million annual hospitalizations in the US, costing billions.
- A significant portion (50%) of AHF cases involve patients with preserved ejection fraction (HFpEF).
- Existing clinical guidelines offer limited evidence-based recommendations for AHF management in HFpEF patients.
Purpose of the Study:
- To review the current epidemiology of AHF in HFpEF.
- To discuss the pathophysiology of AHF in HFpEF.
- To summarize existing treatment approaches for AHF in HFpEF.
Main Methods:
- Literature review of epidemiological data.
- Synthesis of pathophysiological mechanisms.
- Analysis of current therapeutic strategies.
Main Results:
- AHF represents a substantial healthcare burden, with HFpEF patients constituting a large subgroup.
- Pathophysiology of HFpEF in AHF is complex and not fully elucidated.
- Evidence-based treatment options for AHF in HFpEF remain limited.
Conclusions:
- There is a critical need for more research and evidence-based guidelines for managing AHF in HFpEF.
- Understanding the unique aspects of HFpEF is crucial for improving AHF patient outcomes.
- Current management strategies require further investigation and refinement for this patient population.
Abstract:
Currently, there are 1.0 million annual hospital discharges for acute heart failure (AHF). The total cost of heart failure (HF) care in the United States is projected to increase to $53 billion in 2030, with the majority of costs (80 %) related to AHF hospitalizations. Approximately 50 % of AHF episodes occur in patients with preserved ejection fraction (HFpEF). There is a dearth of evidence-based guidelines for the management of AHF in HFpEF patients. Here, we briefly review the epidemiology, pathophysiology, and treatment of AHF patients with HFpEF.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Pathophysiology of Heart Failure
Cardiomyopathy V: Interprofessional Care
